New antithrombotic formulation, process for its manufacturing, and use thereof

PCT No. PCT/SE95/01425 Sec. 371 Date Dec. 18, 1995 Sec. 102(e) Date Dec. 18, 1995 PCT Filed Nov. 29, 1995 PCT Pub. No. WO96/16671 PCT Pub. Date Jun. 6, 1996A new pharmaceutical formulation comprising the thrombin inhibitor HOOC-CH2-(R)-Cgl-Aze-Pab in combination with one or more absorption enhancing...

Full description

Saved in:
Bibliographic Details
Main Authors A. L. UNGELL, J. E. LOEFROTH
Format Patent
LanguageEnglish
Published 24.12.1997
Edition6
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PCT No. PCT/SE95/01425 Sec. 371 Date Dec. 18, 1995 Sec. 102(e) Date Dec. 18, 1995 PCT Filed Nov. 29, 1995 PCT Pub. No. WO96/16671 PCT Pub. Date Jun. 6, 1996A new pharmaceutical formulation comprising the thrombin inhibitor HOOC-CH2-(R)-Cgl-Aze-Pab in combination with one or more absorption enhancing agents, a process for the preparation of such a pharmacutical formulation, the use of such a formulation in the treatment of thromboembolism as well as a method of treating a patient in need of antithrombotic treatment and thromboembolism by using said formulation.
Bibliography:Application Number: CN19951096581